A panel of phenotypically and genotypically diverse bioluminescent:fluorescent Trypanosoma cruzi strains as a resource for Chagas disease research

Author:

Olmo Francisco,Jayawardhana Shiromani,Khan Archie A.,Langston Harry C.,Francisco Amanda Fortes,Atherton Richard L.,Ward Alex I.,Taylor Martin C.,Kelly John M.ORCID,Lewis Michael D.

Abstract

Chagas disease is caused by Trypanosoma cruzi, a protozoan parasite that displays considerable genetic diversity. Infections result in a range of pathological outcomes, and different strains can exhibit a wide spectrum of anti-parasitic drug tolerance. The genetic determinants of infectivity, virulence and therapeutic susceptibility remain largely unknown. As experimental tools to address these issues, we have generated a panel of bioluminescent:fluorescent parasite strains that cover the diversity of the T. cruzi species. These reporters allow spatio-temporal infection dynamics in murine models to be monitored in a non-invasive manner by in vivo imaging, provide a capability to detect rare infection foci at single-cell resolution, and represent a valuable resource for investigating virulence and host:parasite interactions at a mechanistic level. Importantly, these parasite reporter strains can also contribute to the Chagas disease drug screening cascade by ensuring that candidate compounds have pan-species in vivo activity prior to being advanced into clinical testing. The parasite strains described in this paper are available on request.

Funder

Medical Research Council

Drugs for Neglected Diseases initiative

Publisher

Public Library of Science (PLoS)

Reference51 articles.

1. WHO (2023) https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis).

2. Diagnosis and management of Chagas disease and cardiomyopathy.;AL Ribeiro;Nat Rev Cardiol,2012

3. Chagas disease cardiomyopathy: immunopathology and genetics;E Cunha-Neto;Mediat Inflamm,2014

4. Trypanocidal drugs: mechanisms, resistance and new targets.;SR Wilkinson;Exp Rev Molec Med,2009

5. Current and future chemotherapy for Chagas disease;L Gaspar;Curr Med Chem,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3